Table 1.
Perioperative Outcomes
| CLSa (n = 86) | RALSa (n = 32) | P Value | |
|---|---|---|---|
| EBLa (range) (mL)b | 100 (50–200) | 100 (50–200) | .8755 |
| ORTa (range) (min)b | 173.50 (123–237) | 250.50 (176–328.50) | .0005d |
| Hysterectomyc | .1065 | ||
| None | 68 (79%) | 24 (75%) | |
| Simple | 18 (21%) | 6 (19%) | |
| Radical | 0 (0%) | 2 (6%) | |
| Hysteroscopyc | .0900 | ||
| Not performed | 36 (42%) | 19 (59%) | |
| Performed | 50 (58%) | 13 (41%) | |
| No. of intraoperative complicationsc | .2712 | ||
| 0 | 86 (100%) | 31 (97%) | |
| 1 | 0 (0%) | 1 (3%) | |
| No. of postoperative complicationsc | .6570 | ||
| 0 | 76 (88%) | 27 (84%) | |
| 1 | 8 (9%) | 4 (13%) | |
| 2 | 1 (1.5%) | 0 (0%) | |
| 3 | 1 (1.5%) | 1 (3%) | |
| LOSa (range) (d)b | 1 (0–2) | 1 (0–2) | .5582 |
a
CLS = conventional laparoscopic surgery; EBL = estimated blood loss; LOS = length of stay in hospital after surgery; ORT = operating room time; RALS = robotic-assisted laparoscopic surgery.
b
Wilcoxon rank sum test at 5% (2-sided) level of significance.
c
Chi-square test, or Fisher exact test when expected cell counts were <5, at 5% (2-sided) level of significance.
d
P < .05.